List of insiders holdings for Scorpius Holdings Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Wolf Jeffrey Alan Chief Executive Officer | 2024-05-21 17:25:39 | 6,636,178 0 | 6,636,178 | Form 13D |
Wolf Jeffrey Alan Orion Holdings V LLC Seed-One Holdings VI LLC Chief Executive Officer 10% Owner | 2024-05-21 17:25:39 | 6,636,178 0 | 6,636,178 | Form 13D |
KHARITONOV MICHAEL Director | 2016-03-23 20:12:17 | 1,624,960 0 | 1,624,960 | Form 4 |
ARISTAR CAPITAL MANAGEMENT LLC ARISTAR HEAT LLC ARISTAR CAPITAL MANAGEMENT GP LLC 10% Owner | 2017-02-14 17:41:08 | 754,554 0 | 754,554 | Form 13D |
BRIGHTLINE CAPITAL MANAGEMENT LLC Brightline Ventures III LLC BRIGHTLINE HEAT LLC BRIGHTLINE GP LLC Smith Edward B III KHERA NICK 10% Owner | 2013-07-29 16:50:42 | 697,303 0 | 697,303 | Form 13D |
Hutchins Jeff Tobin CSO and COO | 2020-03-16 07:00:47 | 500,000 0 | 500,000 | Form 4 |
Ostrander William L. CFO/Corp Secy | 2022-12-09 16:59:13 | 490,196 0 | 490,196 | Form 4 |
FW Heat Investors L.P. 10% Owner | 2014-02-12 15:01:06 | 453,763 0 | 453,763 | Form 13G |
Rosar Ann A VP of Finance | 2019-01-03 16:50:42 | 203,949 0 | 203,949 | Form 4 |
PRENDERGAST JOHN K A Director | 2022-12-09 17:00:34 | 203,921 0 | 203,921 | Form 4 |
Smith Edward B III Director | 2022-12-09 17:01:55 | 101,960 0 | 101,960 | Form 4 |
MONAHAN JOHN J Director | 2022-12-09 16:58:34 | 101,960 0 | 101,960 | Form 4 |
Jakobs Robert James VP Finance/Controller/Secty | 2019-04-01 21:19:31 | 75,000 0 | 75,000 | Form 4 |
CREECH TIMOTHY J Chief Financial Officer | 2015-12-01 09:37:38 | 70,000 0 | 70,000 | Form 4 |
Schreiber Taylor Chief Scientific Officer | 2016-01-13 17:20:25 | 57,567 0 | 57,567 | Form 4 |
Price Melissa VP of Product Development | 2016-01-13 17:20:24 | 51,587 0 | 51,587 | Form 4 |
CZAJKOWSKI MATTHEW E Chief Financial Officer | 2014-01-21 16:15:10 | 48,364 0 | 48,364 | Form 4 |
Harris Jennifer Lynn VP Clinical/Regulatory Affairs | 2013-07-23 17:26:24 | 30,436 0 | 30,436 | Form 3 |
Belsky Paul Director | 2016-01-13 17:20:24 | 23,810 0 | 23,810 | Form 4 |
BOCK LOUIS C Director | 2016-01-13 17:20:24 | 23,810 0 | 23,810 | Form 4 |
Goyal Anil K. VP of Business Development | 2016-01-13 17:20:25 | 21,587 0 | 21,587 | Form 4 |
Silberman Sandra Chief Medical Officer | 2013-07-23 17:28:27 | 19,566 0 | 19,566 | Form 3 |
Deyev Vadim Director of Applied Research | 2013-07-23 17:25:49 | 10,870 0 | 10,870 | Form 3 |
DiPalma Stephen J. Interim CFO | 2015-03-12 17:15:12 | 0 0 | 0 | Form 3 |